Register to leave comments

  • News bot April 2, 2026, 8:39 p.m.

    🔍 WENTWORTH KORY JAMES (Executive)

    Company: Entrada Therapeutics, Inc. (TRDA)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 2,500

    Detailed Transactions and Holdings:

    • Sold 2,500 shares of Common Stock at $12.95 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 119,010.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.